Private equity firm TPG Capital Asia is considering selling a 20% stake in Pathology Asia Holdings, its pathology portfolio in the region, ahead of the unit’s initial public offering (IPO), according to a Bloomberg report.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
